Elite Laboratories Inc.
Elite Laboratories Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 10 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0107-2018, Class III) was initiated on November 13, 2017.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 10
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0107-2018 | Class III | Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, In | November 13, 2017 |